Armata Pharmaceuticals, Inc. Share Price
AMEX: ARMP | Micro CapArmata Pharmaceuticals, Inc. Stock Performance
Open $5.32 | Prev. Close $5.34 | Circuit Range N/A |
Day Range $5.07 - $5.33 | Year Range $2.49 - $16.34 | Volume 2,052 |
Average Traded $5.26 |
Armata Pharmaceuticals, Inc. Share Price Today
As of 30 August 2026, Armata Pharmaceuticals, Inc.'s share price is $5.31. The stock opened at $5.32, compared to its previous close of $5.34. During today's trading session, Armata Pharmaceuticals, Inc.'s share price traded between $5.07 and $5.33, with an average price of $5.20. Over the past 52 weeks, the stock has recorded a high of $16.34 and a low of $2.49. In terms of performance, Armata Pharmaceuticals, Inc.'s share price has declined by 50.42% over the last six months and is up 111.98% on a year-on-year basis.
Armata Pharmaceuticals, Inc. Share Price Chart
Armata Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators
Market Cap $192.43M | PE Ratio (TTM) -1.11 | Dividend Yield N/A |
EPS (TTM) $-4.80 | Revenue (TTM) $4.90M | Return On Equity (TTM) 79.51% |
Profit Margin -3544.03% | Debt to Equity -0.04 | Quarterly Earnings Growth YoY -386.68% |
Armata Pharmaceuticals, Inc. Quarterly Profit & Loss
All figures in USD
Armata Pharmaceuticals, Inc. Annual Profit & Loss
All figures in USD
About Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.
Armata Pharmaceuticals, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $4.72 | $5.34 | +16.59% |
Jul 2026 | $6.45 | $4.58 | -28.66% |
Jun 2026 | $8.03 | $6.42 | -20.64% |
May 2026 | $9.24 | $8.09 | -18.45% |
Apr 2026 | $10.16 | $9.92 | +15.21% |
Mar 2026 | $11.44 | $8.61 | -19.61% |
Feb 2026 | $7.04 | $10.71 | +57.50% |
Jan 2026 | $6.49 | $6.80 | +7.42% |
Dec 2025 | $7.08 | $6.33 | -12.51% |
Nov 2025 | $4.76 | $7.24 | +49.18% |
Oct 2025 | $3.01 | $4.85 | +62.21% |
Sep 2025 | $2.70 | $2.99 | +19.36% |
ARMP Share Price FAQs
What is Armata Pharmaceuticals, Inc. share price today?
What is the 52 week high and 52 week low of Armata Pharmaceuticals, Inc. stock?
What is ARMP's market capitalisation today?
What is ARMP's net income for the last quarter?
What is the 5 year returns of ARMP?
What is the high & low stock price of ARMP today?
Can I buy ARMP shares in India?